doi:10.3969/j.issn.1674-490X.2021.02.004

Abstract

Abstract: Depression is the most common complication of ischemic stroke, which has a great negative impact on the functional recovery and quality of life of survivors.About 1/3 people are affected by post-stroke depression, which makes it a serious social and public health problem.Reasonable prevention and treatment of post-stroke depression requires a comprehensive understanding of the pathophysiological factors of the disease.A detailed review of the etiology and pathogenesis of post-stroke depression can provide a more comprehensive and systematic scientific basis for the prevention and treatment of this disease in the future.

Key words: stroke, depression, etiology, pathogenesis

CLC Number:

R743

References

[1] MITCHELL A J, SHETH B, GILL J, et al.Prevalence and predictors of post-stroke mood disorders: a meta-analysis and meta-regression of depression, anxiety and adjustment disorder[J].Gen Hosp Psychiatry, 2017, 47: 48-60.DOI: 10.1016/j.genhosppsych.2017.04.001.
[2] CAI W, MUELLER C, LI Y J, et al.Post stroke depression and risk of stroke recurrence and mortality: a systematic review and meta-analysis[J].Ageing Res Rev, 2019, 50: 102-109.DOI: 10.1016/j.arr.2019.01.013.
[3] YUAN H W, WANG C X, ZHANG N, et al.Poststroke depression and risk of recurrent stroke at 1 year in a Chinese cohort study[J].PLoS One, 2012, 7(10): e46906.DOI: 10.1371/journal.pone.0046906.
[4] DONG L M, SÁNCHEZ B N, SKOLARUS L E, et al.Sex difference in prevalence of depression after stroke[J].Neurology, 2020, 94(19): e1973-e1983.DOI: 10.1212/wnl.0000000000009394.
[5] DONG L M, SÁNCHEZ B N, SKOLARUS L E, et al.Ethnic differences in prevalence of post-stroke depression[J].Circ Cardiovasc Qual Outcomes, 2018, 11(2): e004222.DOI: 10.1161/CIRCOUTCOMES.117.004222.
[6] FEI K Z, BENN E K, NEGRON R, et al.Prevalence of depression among stroke survivors: racial-ethnic differences[J].Stroke, 2016, 47(2): 512-515.DOI: 10.1161/STROKEAHA.115.010292.
[7] DE RYCK A, FRANSEN E, BROUNS R, et al.Psychosocial problems associated with depression at 18 months poststroke[J].Int J Geriatr Psychiatry, 2014, 29(2): 144-152.DOI: 10.1002/gps.3974.
[8] ANGUELOVA M, BENKELFAT C, TURECKI G.A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I.Affective disorders[J].Mol Psychiatry, 2003, 8(6): 574-591.DOI: 10.1038/sj.mp.4001328.
[9] MAK K K, KONG W Y, MAK A, et al.Polymorphisms of the serotonin transporter gene and post-stroke depression: a meta-analysis[J].J Neurol Neurosurg Psychiatry, 2013, 84(3): 322-328.DOI: 10.1136/jnnp-2012-303791.
[10] KOHEN R, CAIN K C, MITCHELL P H, et al.Association of serotonin transporter gene polymorphisms with poststroke depression[J].Arch Gen Psychiatry, 2008, 65(11): 1296-1302.DOI: 10.1001/archpsyc.65.11.1296.
[11] ZHAO Q, GUO Y, YANG D, et al.Serotonin transporter gene 5-HTTLPR polymorphism as a protective factor against the progression of post-stroke depression[J].Mol Neurobiol, 2016, 53(3): 1699-1705.DOI: 10.1007/s12035-015-9120-7.
[12] WANG Y K, LIU H Y, JIANG Y, et al.Meta-analysis of 5-hydroxytryptamine transporter gene promoter region polymorphism and post-stroke depression[J].J Int Med Res, 2020, 48(6): 300060520925943.DOI: 10.1177/0300060520925943.
[13] GATT J M, NEMEROFF C B, DOBSON-STONE C, et al.Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety[J].Mol Psychiatry, 2009, 14(7): 681-695.DOI: 10.1038/mp.2008.143.
[14] KIM J M, STEWART R, BAE K Y, et al.Serotonergic and BDNF genes and risk of depression after stroke[J].J Affect Disord, 2012, 136(3): 833-840.DOI: 10.1016/j.jad.2011.09.029.
[15] JIN H J, PEI L, LI Y N, et al.Alleviative effects of fluoxetine on depressive-like behaviors by epigenetic regulation of BDNF gene transcription in mouse model of post-stroke depression[J].Sci Rep, 2017, 7(1): 14926.DOI: 10.1038/s41598-017-13929-5.
[16] ZHOU Z M, LU T T, XU G L, et al.Decreased serum brain-derived neurotrophic factor(BDNF)is associated with post-stroke depression but not with BDNF gene Val66Met polymorphism[J].Clin Chem Lab Med, 2011, 49(2): 185-189.DOI: 10.1515/CCLM.2011.039.
[17] BERG C, BACKSTRÖM T, WINBERG S, et al.Developmental exposure to fluoxetine modulates the serotonin system in hypothalamus[J].PLoS One, 2013, 8(1): e55053.DOI: 10.1371/journal.pone.0055053.
[18] JI X W, WU C L, WANG X C, et al.Monoamine neurotransmitters and fibroblast growth factor-2 in the brains of rats with post-stroke depression[J].Exp Ther Med, 2014, 8(1): 159-164.DOI: 10.3892/etm.2014.1674.
[19] ZAHRAI A, VAHID-ANSARI F, DAIGLE M, et al.Fluoxetine-induced recovery of serotonin and norepinephrine projections in a mouse model of post-stroke depression[J].Transl Psychiatry, 2020, 10(1): 334.DOI: 10.1038/s41398-020-01008-9.
[20] ZHANG X F, ZOU W, YANG Y.Effects of IL-6 and cortisol fluctuations in post-stroke depression[J].Huazhong Univ Sci Technolog Med Sci, 2016, 36(5): 732-735.DOI: 10.1007/s11596-016-1653-0.
[21] SCHIEPERS O J, WICHERS M C, MAES M.Cytokines and major depression[J].Prog Neuropsychopharmacol Biol Psychiatry, 2005, 29(2): 201-217.DOI: 10.1016/j.pnpbp.2004.11.003.
[22] KOO Y S, KIM H, PARK J H, et al.Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism contributes to poststroke depression induced in mice by ischemic stroke along with spatial restraint stress[J].Oxid Med Cell Longev, 2018, 2018: 2413841.DOI: 10.1155/2018/2413841.
[23] WU D, ZHANG G C, ZHAO C Y, et al.Interleukin-18 from neurons and microglia mediates depressive behaviors in mice with post-stroke depression[J].Brain Behav Immun, 2020, 88: 411-420.DOI: 10.1016/j.bbi.2020.04.004.
[24] CHEN Y, PU J C, LIU Y Y, et al.Pro-inflammatory cytokines are associated with the development of post-stroke depression in the acute stage of stroke: a meta-analysis[J].Top Stroke Rehabil, 2020: 1-10.DOI: 10.1080/10749357.2020.1755813.
[25] MEISEL C, SCHWAB J M, PRASS K, et al.Central nervous system injury-induced immune deficiency syndrome[J].Nat Rev Neurosci, 2005, 6(10): 775-786.DOI: 10.1038/nrn1765.
[26] KATON W J.Epidemiology and treatment of depression in patients with chronic medical illness[J].Dialogues Clin Neurosci, 2011, 13(1): 7-23.DOI: 10.31887/DCNS.2011.13.1/wkaton.
[27] WU R H, FENG C, XU Y, et al.Late-onset depression in the absence of stroke: associated with silent brain infarctions, microbleeds and lesion locations[J].Int J Med Sci, 2014, 11(6): 587-592.DOI: 10.7150/ijms.8025.
[28] WEI N, YONG W, LI X Y, et al.Post-stroke depression and lesion location: a systematic review[J].J Neurol, 2015, 262(1): 81-90.DOI: 10.1007/s00415-014-7534-1.
[29] GONG Q Y, HE Y.Depression, neuroimaging and connectomics: a selective overview[J].Biol Psychiatry, 2015, 77(3): 223-235.DOI: 10.1016/j.biopsych.2014.08.009.
[30] VAHID-ANSARI F, LAGACE D C, ALBERT P R.Persistent post-stroke depression in mice following unilateral medial prefrontal cortical stroke[J].Transl Psychiatry, 2016, 6(8): e863.DOI: 10.1038/tp.2016.124.
[31] ZHANG T, JING X, ZHAO X Q, et al.A prospective cohort study of lesion location and its relation to post-stroke depression among Chinese patients[J].J Affect Disord, 2012, 136(1/2): e83-e87.DOI: 10.1016/j.jad.2011.06.014.
[32] ZHANG L, SUI R B.Proton magnetic resonance spectroscopy study on the metabolism changes of cerebellum in patients with post-stroke depression[J].Cell Physiol Biochem, 2017, 41(4): 1393-1402.DOI: 10.1159/000467907.

Related Articles 15

[1]	. [J]. Journal of Hebei Medical College for Continuing Education, 2023, 40(4): 19-24.
[2]	. [J]. Journal of Hebei Medical College for Continuing Education, 2023, 40(3): 28-37.
[3]	. [J]. Journal of Hebei Medical College for Continuing Education, 2023, 40(3): 46-54.
[4]	. [J]. Journal of Hebei Medical College for Continuing Education, 2023, 40(2): 10-17.
[5]	. [J]. Journal of Hebei Medical College for Continuing Education, 2023, 40(2): 18-24.
[6]	. [J]. Journal of Hebei Medical College for Continuing Education, 2023, 40(2): 66-73.
[7]	. [J]. Journal of Hebei Medical College for Continuing Education, 2023, 40(1): 29-32.
[8]	. [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(6): 53-57.
[9]	HUANG Xianyi, LIU Shuang, LIU Yan, YUE Jie, CHEN Li. Research status of fear disease progression in stroke patients [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(5): 68-74.
[10]	XIE Ruijuan, DENG Yun, LIU Juan, YANG Nan,ZHANG Kun. Effect of enhanced sensory stimulation-oriented facilitation technique in the rehabilitation of upper limb function after stroke [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(4): 14-21.
[11]	WANG Jing, HAN Li, ZHANG Zeming. Advances on chronic obstructive pulmonary disease associated pulmonary hypertension [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(3): 21-28.
[12]	ZHANG Jinghui,ZHAO Hanqing,WANG Zewen,XIANG Hongwei,GE Shaoqin. Simple obesity and application of TCM Piwei theory [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(3): 54-59.
[13]	ZHU Jianping, LI Yunman. The key role of Nrf2 in ischemic stroke [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(2): 1-9.
[14]	. [J]. Journal of Hebei Medical College for Continuing Education, 2021, 38(6): 8-14.
[15]	. [J]. Journal of Hebei Medical College for Continuing Education, 2021, 38(6): 36-43.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments